Database	Time span	Search strategy
The Cochrane Hepato‐Biliary Group Controlled Trials Register	Date will be given at review stage	((Magnetic AND resonance) OR MR*) AND (gadoxet* OR gadolinium* OR primovist OR eovist OR Gd‐EOB* OR EOB*) AND (((liver OR hepato*) AND (carcinom* OR cancer* OR neoplasm* OR malign* OR tumo*)) OR hepatoma OR HCC)
The Cochrane Hepato‐Biliary Group Diagnostic Test of Accuracy Studies Register	Date will be given at review stage	((Magnetic AND resonance) OR MR*) AND (gadoxet* OR gadolinium* OR primovist OR eovist OR Gd‐EOB* OR EOB*) AND (((liver OR hepato*) AND (carcinom* OR cancer* OR neoplasm* OR malign* OR tumo*)) OR hepatoma OR HCC)
The Cochrane Library	Latest issue	#1 MeSH descriptor: [Magnetic Resonance Imaging] explode all trees #2 (Magnetic and resonance) or MR* #3 #1 or #2 #4 MeSH descriptor: [Gadolinium DTPA] explode all trees #5 gadoxet* or gadolinium or primovist or eovist or Gd‐EOB* or EOB* #6 #4 or #5 #7 MeSH descriptor: [Liver Neoplasms] explode all trees #8 ((liver or hepato*) and (carcinom* or cancer* or neoplasm* or malign* or tumo*)) or hepatoma or HCC #9 #7 or #8 #10 #3 and #6 and #9
MEDLINE (OvidSP)	1946 to the date of search	1. exp Magnetic Resonance Imaging/ 2. ((Magnetic and resonance) or MR*).mp. [mp=title, abstract, original title, name of substance word, subject heading word, keyword heading word, protocol supplementary concept word, rare disease supplementary concept word, unique identifier] 3. 1 or 2 4. exp Gadolinium DTPA/ 5. (gadoxet* or gadolinium or primovist or eovist or Gd‐EOB* or EOB*).mp. [mp=title, abstract, original title, name of substance word, subject heading word, keyword heading word, protocol supplementary concept word, rare disease supplementary concept word, unique identifier] 6. 4 or 5 7. exp Liver Neoplasms/ 8. (((liver or hepato*) and (carcinom* or cancer* or neoplasm* or malign* or tumo*)) or hepatoma or HCC).mp. [mp=title, abstract, original title, name of substance word, subject heading word, keyword heading word, protocol supplementary concept word, rare disease supplementary concept word, unique identifier] 9. 7 or 8 10. 3 and 6 and 9
Embase (OvidSP)	1974 to the date of search	1. exp nuclear magnetic resonance imaging/ 2. ((Magnetic and resonance) or MR*).mp. [mp=title, abstract, heading word, drug trade name, original title, device manufacturer, drug manufacturer, device trade name, keyword] 3. 1 or 2 4. exp gadoxetic acid/ 5. (gadoxet* or gadolinium* or primovist or eovist or Gd‐EOB* or EOB*).mp. [mp=title, abstract, heading word, drug trade name, original title, device manufacturer, drug manufacturer, device trade name, keyword] 6. 4 or 5 7. exp liver tumor/ 8. (((liver or hepato*) and (carcinom* or cancer* or neoplasm* or malign* or tumo*)) or hepatoma or HCC).mp. [mp=title, abstract, heading word, drug trade name, original title, device manufacturer, drug manufacturer, device trade name, keyword] 9. 7 or 8 10. 3 and 6 and 9
Science Citation Index EXPANDED	1900 to the date of search	#4 #3 AND #2 AND #1 #3 TS=(((liver or hepato*) and (carcinom* or cancer* or neoplasm* or malign* or tumo*)) or hepatoma or HCC) #2 TS=(gadoxet* OR gadolinium* OR primovist OR eovist OR Gd‐EOB* OR EOB*) #1 TS=((Magnetic and resonance) or MR OR MRI)